Increases prognostic value of clinical-pathological nomogram in patients with esophageal squamous cell carcinoma

Background This study was intended to construct a brand new prognostic nomogram after combine clinical and pathological characteristics to increases prognostic value in patients with esophageal squamous cell carcinoma. Methods A total of 1,634 patients were included. Subsequently, the tumor tissues of all patients were prepared into tissue microarrays. AIPATHWELL software was employed to explore tissue microarrays and calculate the tumor-stroma ratio. X-tile was adopted to find the optimal cut-off value. Univariate and multivariate Cox analyses were used to screen out remarkable characteristics for constructing the nomogram in the total populations. A novel prognostic nomogram with clinical and pathological characteristics was constructed on the basis of the training cohort (n=1,144). What’s more performance was validated in the validation cohort (n=490). Clinical-pathological nomogram were assessed by concordance index, time-dependent receiver operating characteristic, calibration curve and decision curve analysis. Results The patients can divide into two groups with cut-off value of 69.78 for the tumor-stroma ratio. It is noteworthy that the survival difference was noticeable (P<0.001). A clinical-pathological nomogram was constructed by combining clinical and pathological characteristics to predict the overall survival. In comparison with TNM stage, the concordance index and time-dependent receiver operating characteristic of the clinical-pathological nomogram showed better predictive value (P<0.001). High quality of calibration plots in overall survival was noticed. As demonstrated by the decision curve analysis, the nomogram has better value than the TNM stage. Conclusions As evidently revealed by the research findings, tumor-stroma ratio is an independent prognostic factor in patients with esophageal squamous cell carcinoma. The clinical-pathological nomogram has an incremental value compared TNM stage in predicting overall survival.

[1]  Jingping Yuan,et al.  Tumour stroma ratio is a potential predictor for 5-year disease-free survival in breast cancer , 2022, BMC Cancer.

[2]  Fan Wang,et al.  Family history of malignant tumor is a predictor of gastric cancer prognosis: Incorporation into a nomogram , 2022, Medicine.

[3]  F. Zhou,et al.  Focal amplifications are associated with chromothripsis events and diverse prognoses in gastric cardia adenocarcinoma , 2021, Nature Communications.

[4]  S. Ricard-Blum,et al.  A guide to the composition and functions of the extracellular matrix , 2021, The FEBS journal.

[5]  F. Zhou,et al.  Preoperative maximal voluntary ventilation, hemoglobin, albumin, lymphocytes and platelets predict postoperative survival in esophageal squamous cell carcinoma , 2021, World journal of gastroenterology.

[6]  Jonathan W. Song,et al.  The Roles of Stroma-Derived Chemokine in Different Stages of Cancer Metastases , 2020, Frontiers in Immunology.

[7]  Jie He,et al.  Selection of high‐risk individuals for esophageal cancer screening: A prediction model of esophageal squamous cell carcinoma based on a multicenter screening cohort in rural China , 2020, International journal of cancer.

[8]  Mengjuan Zhang,et al.  T Cells in Fibrosis and Fibrotic Diseases , 2020, Frontiers in Immunology.

[9]  Jie Wu,et al.  A nomogram for predicting overall survival in patients with low‐grade endometrial stromal sarcoma: A population‐based analysis , 2020, Cancer communications.

[10]  Xin Song,et al.  Characterization of 500 Chinese patients with cervical esophageal cancer by clinicopathological and treatment outcomes , 2020, Cancer biology & medicine.

[11]  Peter K. Lambert.  Population Analysis , 2020, Definitions.

[12]  Rui Wei,et al.  Cellular and Extracellular Components in Tumor Microenvironment and Their Application in Early Diagnosis of Cancers , 2020, Analytical cellular pathology.

[13]  Q. Lv,et al.  A nomogram for individualized estimation of survival among adult patients with adrenocortical carcinoma after surgery: a retrospective analysis and multicenter validation study , 2019, Cancer communications.

[14]  Shuye Liu,et al.  The prognostic analysis of different metastatic patterns in pancreatic neuroendocrine tumors patients , 2019, Medicine.

[15]  Jun Lyu,et al.  Nomogram for predicting the survival of patients with malignant melanoma: A population analysis , 2019, Oncology letters.

[16]  S. Thrumurthy,et al.  Oesophageal cancer: risks, prevention, and diagnosis , 2019, BMJ.

[17]  M. Karsdal,et al.  Collagens and Cancer associated fibroblasts in the reactive stroma and its relation to Cancer biology , 2019, Journal of experimental & clinical cancer research : CR.

[18]  Y. Mao,et al.  Prognostic impact of family history of cancer in Southern Chinese patients with esophageal squamous cell cancer , 2019, Journal of Cancer.

[19]  Shidan Wang,et al.  Development and Validation of a Nomogram Prognostic Model for SCLC Patients , 2018, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[20]  T. Greene,et al.  A simple method to estimate the time-dependent receiver operating characteristic curve and the area under the curve with right censored data , 2018, Statistical methods in medical research.

[21]  H. Putter,et al.  Prognostic value of tumor–stroma ratio combined with the immune status of tumors in invasive breast carcinoma , 2017, Breast Cancer Research and Treatment.

[22]  T. Ng,et al.  In Vivo Imaging of Pro- and Antitumoral Cellular Components of the Tumor Microenvironment , 2017, The Journal of Nuclear Medicine.

[23]  Jesper Lagergren,et al.  Oesophageal cancer , 2017, The Lancet.

[24]  C. Abnet,et al.  Epidemiology of Esophageal Squamous Cell Carcinoma. , 2017, Gastroenterology.

[25]  Y. Qiao,et al.  Esophageal cancer in high-risk areas of China: research progress and challenges. , 2017, Annals of epidemiology.

[26]  M. Falconi,et al.  The tumor microenvironment promotes cancer progression and cell migration , 2016, Oncotarget.

[27]  R. Weber,et al.  Prognostic nomogram for refining the prognostication of the proposed 8th edition of the AJCC/UICC staging system for nasopharyngeal cancer in the era of intensity‐modulated radiotherapy , 2016, Cancer.

[28]  S. Roman,et al.  Exploring the Relationship Between Patient Age and Cancer-Specific Survival in Papillary Thyroid Cancer: Rethinking Current Staging Systems. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[29]  Rajesh Talluri,et al.  Using the weighted area under the net benefit curve for decision curve analysis , 2016, BMC Medical Informatics and Decision Making.

[30]  Birgit Kasch,et al.  Next Generation , 2016, Im OP.

[31]  A. Theocharis,et al.  Extracellular matrix structure. , 2016, Advanced drug delivery reviews.

[32]  Hongwei Cheng,et al.  Family history of esophageal cancer increases the risk of esophageal squamous cell carcinoma , 2015, Scientific Reports.

[33]  Ying Chen,et al.  Prognostic Significance of the Tumor-Stroma Ratio in Epithelial Ovarian Cancer , 2015, BioMed research international.

[34]  Haiyang Xie,et al.  Tumor-stroma ratio is a prognostic factor for survival in hepatocellular carcinoma patients after liver resection or transplantation. , 2015, Surgery.

[35]  Mithat Gonen,et al.  Nomograms in oncology: more than meets the eye. , 2015, The Lancet. Oncology.

[36]  H. Kuh,et al.  Improving drug delivery to solid tumors: priming the tumor microenvironment. , 2015, Journal of controlled release : official journal of the Controlled Release Society.

[37]  V. Biron,et al.  Association of keratinization with 5-year disease-specific survival in oropharyngeal squamous cell carcinoma. , 2015, JAMA otolaryngology-- head & neck surgery.

[38]  M. Mazzone,et al.  Tumor stroma: a complexity dictated by the hypoxic tumor microenvironment , 2014, Oncogene.

[39]  Houqiang Liu,et al.  Tumor-Stroma Ratio Is an Independent Predictor for Survival in Esophageal Squamous Cell Carcinoma , 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[40]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[41]  D. Rimm,et al.  X-Tile , 2004, Clinical Cancer Research.

[42]  S. Nee.  More than meets the eye , 2004, Nature.

[43]  Ash A. Alizadeh,et al.  Software tools for high-throughput analysis and archiving of immunohistochemistry staining data obtained with tissue microarrays. , 2002, The American journal of pathology.

[44]  Y. Guanrei,et al.  Endoscopic Surveys in High-risk and Low-risk Populations for Esophageal Cancer in China with Special Reference to Precursors of Esophageal Cancer , 1987, Endoscopy.

[45]  D. Wen,et al.  Younger age of onset and multiple primary lesions associated with esophageal squamous cell carcinoma cases with a positive family history of the cancer suggests genetic predisposition. , 2014, Chinese medical journal.

[46]  M. Salto‐Tellez,et al.  Reliability of Tissue Microarrays in Detecting Protein Expression and Gene Amplification in Breast Cancer , 2003, Modern Pathology.